glp-1 kidney New Hope for Disease: Understanding Agonists Potential renoprotective effects of GLP1
Description
Early satiety and reduced appetite are common
An NDA has been filed with the FDA
Comorbidities of diabetes (i.e., hypertension, dyslipidemia, obesity) also have crucial roles in pathophysiology of CKD in diabetes
Diabetes 64 , 25132525 (2015)
Begin with a lower starting dose through PlexusDx to confirm your individual tolerance, and track any nausea or stool changes in your first month
The medication is considered experimental or investigational
